학술논문
Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma
Document Type
Article
Author
Source
In: Blood . (Blood, 1 August 2005, 106(3):1042-1047)
Subject
Language
English
ISSN
00064971